Is compounded semaglutide safe? How do I avoid sketchy providers?

Short answer: maybe — but compounded semaglutide is riskier than an FDA‑approved product, and you should be careful. Below is what to know and exactly how to vet providers.

Why compounded semaglutide is different / what the risks are

• FDA‑approved brand products (Wegovy, Ozempic, Rybelsus) are manufactured under strict FDA controls and go through trials that show consistent potency, sterility (for injectables), labeling and safety. Compounded products are not FDA‑approved finished drugs.
• Risks with compounded injectables include wrong dose, incorrect concentration, contamination (sterility issues), unstable storage, inaccurate labeling, and sourcing API from unreliable suppliers. Sterility lapses with injectables have caused recalls and infections in the past.
• Clinical monitoring still matters: semaglutide can cause nausea, gallbladder problems, pancreatitis, hypoglycemia with other diabetes meds, and has theoretical thyroid C‑cell risks (talk with your clinician).

If you want to avoid sketchy providers — a checklist to follow

1. Prefer FDA‑approved products when possible
   • Ozempic and Wegovy (Novo Nordisk) are FDA‑approved semaglutide injections; Rybelsus is oral semaglutide. These are the safest option from a manufacturing/regulatory standpoint.
2. Use a licensed prescriber who does a proper evaluation and follow‑up
   • Get a medical evaluation (in‑person or a documented telemedicine visit) before starting, and ongoing follow‑up. Avoid services that prescribe without history, vitals, or follow‑up.
   • Check the clinician’s license on your state medical board website.
3. Choose an accredited compounding pharmacy
   • Look for pharmacies accredited by recognized bodies and that state they follow USP <797> (sterile compounding) and USP <800> if relevant. PCAB accreditation (Pharmacy Compounding Accreditation Board) or affiliation with PCCA (Professional Compounding Centers of America) is a plus.
   • Ask the pharmacy for proof of accreditation and their sterile compounding procedures.
   • Example names often used by patients (verify current status yourself): Wedgewood Pharmacy (large, established compounding specialist) and Fagron (global compounding supplier/partner). Important: accreditation and recent inspection records matter more than the name — verify them.
4. Ask for documentation from the pharmacy (and insist on answers)
   • Certificate of Analysis (COA) showing potency and identity for the lot used. Prefer third‑party testing if available.
   • Proof of sterility testing, beyond‑use date, storage instructions, lot number, and return policy.
   • Source of the active pharmaceutical ingredient (API) — avoid pharmacies that can’t tell you where their API comes from.
5. Red flags — walk away if:
   • No prescription or no medical evaluation required.
   • Provider or pharmacy refuses to provide COAs, lot numbers, or accreditation details.
   • Price is dramatically lower than typical but they ship from overseas with no paperwork.
   • Cash‑only, cryptocurrency payments, or requests to bypass normal prescription channels.
   • No follow‑up plan, no monitoring, or no clinician contact after starting.
6. Verify online reputation and regulatory standing
   • Check state pharmacy board for license and any disciplinary actions.
   • Look for recent inspections or recalls. Use resources such as FDA safety alerts and PharmacyChecker / NABP / PCAB sites for pharmacy verification.
7. Prefer injectable handling protocols
   • Because injectable compounding needs sterile environments, prefer pharmacies that explicitly describe USP <797> compliance, laminar flow hoods, environmental monitoring, and staff training.

Practical script to use when calling a pharmacy or clinic

• “Are you PCAB‑accredited or do you follow USP <797> for sterile compounding? Can you send proof?”
• “Can I see the Certificate of Analysis for the lot you’re dispensing?”
• “Where do you source the bulk semaglutide API from?”
• “What is the beyond‑use date and storage instructions? Will my prescriber receive paperwork for follow‑up?”

If you’re unsure or uncomfortable

• Ask your primary care doctor or an endocrinologist/obesity‑medicine specialist for a referral to a reputable compounding pharmacy, or to prescribe an FDA‑approved product. You can find board‑certified obesity medicine doctors via the American Board of Obesity Medicine directory.

Reporting problems

• If you suspect contamination, incorrect dosing, or adverse events from a compounded product, report it to the FDA’s MedWatch and your state pharmacy board.

If you want, tell me:

• whether you’re considering it for diabetes or weight loss, and
• whether you prefer a local pharmacy or mail order

I can help you find accredited compounding pharmacies or give wording you can use to vet a specific clinic or pharmacy you’re looking at.